Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
- Conditions
- Interventions
- First Posted Date
- 2016-10-26
- Last Posted Date
- 2021-10-15
- Lead Sponsor
- Braeburn Pharmaceuticals
- Target Recruit Count
- 1053
- Registration Number
- NCT02946073
- Locations
- 🇺🇸
Aventiv Research, Inc., Columbus, Ohio, United States
🇺🇸International Clinical Research Institute Inc., Overland Park, Kansas, United States
🇺🇸Hassman Research Institute, Berlin, New Jersey, United States
Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242
- Conditions
- Interventions
- First Posted Date
- 2016-07-07
- Last Posted Date
- 2017-07-17
- Lead Sponsor
- Braeburn Pharmaceuticals
- Target Recruit Count
- 7
- Registration Number
- NCT02824666
- Locations
- 🇺🇸
Indiana Clinical Research Center, IU Health University Hospital, Indianapolis, Indiana, United States
Safety and Tolerability of Risperidone Implants
- First Posted Date
- 2016-05-16
- Last Posted Date
- 2020-02-19
- Lead Sponsor
- Braeburn Pharmaceuticals
- Target Recruit Count
- 140
- Registration Number
- NCT02773576
- Locations
- 🇺🇸
Collaborative Neuroscience Network, Garden Grove, California, United States
Phase II Pharmacokinetics Study of CAM2038
- First Posted Date
- 2016-03-16
- Last Posted Date
- 2020-04-30
- Lead Sponsor
- Braeburn Pharmaceuticals
- Target Recruit Count
- 66
- Registration Number
- NCT02710526
- Locations
- 🇺🇸
Parkway Medical, Birmingham, Alabama, United States
🇺🇸Hassman Research Institute, Berlin, New Jersey, United States
🇺🇸The Rivus Wellness & Research Institute, Oklahoma City, Oklahoma, United States
Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder
- Conditions
- Interventions
- First Posted Date
- 2016-02-03
- Last Posted Date
- 2020-05-15
- Lead Sponsor
- Braeburn Pharmaceuticals
- Target Recruit Count
- 228
- Registration Number
- NCT02672111
- Locations
- 🇺🇸
Boyett Health Services Inc, Hamilton, Alabama, United States
🇺🇸Dr Vijapura and Associates, Jacksonville, Florida, United States
🇺🇸Haleyville Clinical Research LLC, Haleyville, Alabama, United States
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
- Conditions
- Interventions
- First Posted Date
- 2016-01-18
- Last Posted Date
- 2020-02-19
- Lead Sponsor
- Braeburn Pharmaceuticals
- Target Recruit Count
- 66
- Registration Number
- NCT02658357
- Locations
- 🇺🇸
Segal Institute for Clinical Research 1201 North 37th Avenue, Hollywood, Florida, United States
Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence
- Conditions
- Interventions
- First Posted Date
- 2016-01-11
- Last Posted Date
- 2019-08-22
- Lead Sponsor
- Braeburn Pharmaceuticals
- Target Recruit Count
- 428
- Registration Number
- NCT02651584
- Locations
- 🇺🇸
Innovative Clinical Research Inc, Lauderhill, Florida, United States
🇺🇸Dr Vijapura and Associates, Jacksonville, Florida, United States
🇺🇸TRY Research, Maitland, Florida, United States
A Multiple Dose Opioid Challenge Study
- First Posted Date
- 2015-11-23
- Last Posted Date
- 2019-11-14
- Lead Sponsor
- Braeburn Pharmaceuticals
- Target Recruit Count
- 47
- Registration Number
- NCT02611752
- Locations
- 🇺🇸
New York Psychiatric Institute, New York, New York, United States
🇺🇸Vince and Associates Clinical Research, Overland Park, Kansas, United States
🇺🇸University of Kentucky, Lexington, Kentucky, United States